Cargando…

Chemotherapy with ceramide in TNBC

Detalles Bibliográficos
Autores principales:	Legembre, Patrick, Micheau, Olivier, Ségui, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671935/ https://www.ncbi.nlm.nih.gov/pubmed/26682260

Ejemplares similares

Sphingolipids modulate the epithelial–mesenchymal transition in cancer
por: Levade, T, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Leveraging MYC as a therapeutic treatment option for TNBC
por: Carey, Jason P.W., et al.
Publicado: (2018)

Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
por: Ferrari, Paola, et al.
Publicado: (2022)

IMPassionate about immunotherapy for TNBC: from change, to revolution and to cure?
por: Vagia, Elena, et al.
Publicado: (2020)

Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
por: Massa, Chiara, et al.
Publicado: (2020)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
por: Godet, Inês, et al.
Publicado: (2021)

Energy balance and the sphingosine-1-phosphate/ceramide axis
por: Green, Cara, et al.
Publicado: (2017)

Novel Role for Ceramides in Colorectal Cancer Liver Metastases
por: Tian, Lucy Lu, et al.
Publicado: (2023)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
por: Cerbelli, Bruna, et al.
Publicado: (2017)

Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
por: He, Jiabei, et al.
Publicado: (2019)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Role of acid sphingomyelinase-induced ceramide generation in response to radiation
por: Sharma, Deepa, et al.
Publicado: (2019)

Membrane Lipids and CFTR: The Yin/Yang of Efficient Ceramide Metabolism
por: Bonfield, Tracey L.
Publicado: (2020)

Small ceramide tames big p53 mutant beast
por: Hill, Ronald A., et al.
Publicado: (2020)

Cardiovascular prognosis: a new role for ceramides and other cardiometabolites
por: Wu, Jasmine M. F., et al.
Publicado: (2020)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)
por: Hong, Jiaxin, et al.
Publicado: (2022)

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

The Tricyclodecan-9-yl-xanthogenate D609 Triggers Ceramide Increase and Enhances FasL-Induced Caspase-Dependent and -Independent Cell Death in T Lymphocytes
por: Milhas, Delphine, et al.
Publicado: (2012)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023)

Ceramides, Autophagy, and Apoptosis Mechanisms of Ventilator-induced Lung Injury and Potential Therapeutic Targets
por: Mandell, Erica W., et al.
Publicado: (2019)

Ceramide and ceramide 1-phosphate in health and disease
por: Arana, Lide, et al.
Publicado: (2010)

Intracellular trafficking of ceramide by ceramide transfer protein
por: Hanada, Kentaro
Publicado: (2010)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
por: Choi, Hoon Sik, et al.
Publicado: (2021)

Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy
por: Kim, Sanghwa, et al.
Publicado: (2016)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
por: Koni, Malvina, et al.
Publicado: (2022)

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2022)

TNF-R1, an immune checkpoint in melanoma?
por: Bertrand, Florie, et al.
Publicado: (2015)

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
por: Cazzaniga, M. E., et al.
Publicado: (2021)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
por: Camorani, Simona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v31bfaedf3fm8diic2ojvusdq